Position in DHR
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$700,014
+$141,453 QoQ
Shares Held
3,675
+24.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,216
of 2,098 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026CIDEL ASSET MANAGEMENT INC holds $2,829,572 across 6 Diagnostics & Research names. DHR ranks #2 (24.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,183 | $1,094,468 | |
| 2 | DHR |
Danaher Corp /De/
This page
|
3,675 | $700,014 | |
| 3 | LH |
Labcorp Holdings Inc.
|
1,152 | $322,560 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
1,345 | $259,880 | |
| 5 | DGX |
Quest Diagnostics Inc
|
1,069 | $226,574 | |
| 6 | A |
Agilent Technologies, Inc.
|
1,702 | $226,076 |
All Filings in DHR
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $700,014 | 3,675 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $558,561 | 2,946 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $548,492 | 2,396 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $460,954 | 2,325 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $423,920 | 2,146 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $400,775 | 1,955 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $415,485 | 1,810 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $475,414 | 1,710 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $405,756 | 1,624 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $405,545 | 1,624 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $362,278 | 1,566 | Shares | Sole | 2024-02-12 | |
| No filing history on record for this holder in this stock. | ||||||